Minovia Therapeutics Announces FDA Clearance of IND Application for a Phase Ib Clinical Trial of MNV-201 in Low Risk Myelodysplastic Syndrome
TORONTO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ('Axiom'), a premier provider of unified eClinical solutions and services focused on...